Hepion Pharmaceuticals, Inc. (CTRVP) — 10-K/A Filings
All 10-K/A filings from Hepion Pharmaceuticals, Inc.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (2)
-
Hepion Pharmaceuticals Files 2023 Annual Report Amendment
— Jan 13, 2025 Risk: low
Hepion Pharmaceuticals, Inc. filed an amendment (No. 2) to its 2023 annual report on January 13, 2025. The company, formerly ContraVir Pharmaceuticals, Inc., is -
Hepion Pharmaceuticals Files 2023 Annual Report Amendment
— Jun 25, 2024 Risk: medium
Hepion Pharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the year ended December 31, 2023. The company, formerly known as ContraVir Pha
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX